Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djouzi, Z.
Right arrow Articles by Szylit, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djouzi, Z.
Right arrow Articles by Szylit, O.

The Journal of Nutrition Vol. 127 No. 11 November 1997, pp. 2260-2266
Copyright ©1997 by the American Society for Nutritional Sciences

The Association of Yogurt Starters with Lactobacillus casei DN 114.001 in Fermented Milk Alters the Composition and Metabolism of Intestinal Microflora in Germ-Free Rats and in Human Flora-Associated Rats1

Zakia Djouzi, Claude Andrieux2, Marie-Christine Degivry*, Christine Bouley*, and Odette Szylit

Unité d'Ecologie et de Physiologie du Système Digestif, Équipe Métabolites Bactériens et Santé, INRA, 78352 Jouy en Josas Cedex, France and * CIRDC, Danone, 92350 Le Plessis-Robinson, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
FOOTNOTES
LITERATURE CITED


ABSTRACT

The aim of this study was to compare the effects of milk and of various fermented milks on the composition and metabolic activities of the intestinal microflora. Groups of eight rats were fed for 6 wk a diet containing 30% nonfermented milk (M), yogurt (Y), milk fermented with Lactobacillus casei (LcFM) or milk fermented with the association of L. casei DN 114.001 and yogurt starters (LcYFM). In the first study, the survival of the lactic acid bacteria from the fermented milks was assessed by bacterial enumeration in feces of germ-free rats (GF rats) fed milk or fermented milks. The metabolic activities of the lactic acid bacteria were studied in these rats by the measurement of glycolytic activities and products of bacterial fermentation, i.e., acetate and lactate (isoforms L and D). In a second study, the effects of fermented milks on the composition and metabolism [gas, glycolytic activities, short-chain fatty acids (SCFA), alcohol and ammonia] of human flora were studied using human flora-associated rats (HF rats). In GF rats, the survival of L. casei in the feces did not differ between those fed the LcFM and LcYFM diets. L. bulgaricus was detected in the feces of the rats fed Y, whereas Streptoccus thermophilus was found in the feces of the LcYFM group. In HF rats, fecal concentration of Bifidobacteria was greater in the LcFM group than in the others. beta -Glucuronidase (EC 3.2.1.31) activity was lower in rats fed LcFM and Y than in those fed M and LcYFM, whereas beta -galactosidase (3.2.1.23), alpha -glucosidase (EC 3.2.1 20) and beta -glucosidase (EC 3.2.1.21) activities were higher in the LcYFM group compared with the others. Methane excretion was higher in rats fed Y than in other groups. Cecal SCFA concentrations did not differ in LcFM, Y and M groups, but total SCFA, acetate, propionate and butyrate were significantly greater in the LcYFM group. These results suggest that milk fermented with the combination of L. casei and yogurt starters leads to specific effects that are different from the simple addition of the effects found with yogurt and milk fermented with L. casei. These specific effects are potentially beneficial to human health.

KEY WORDS: fermented milk · gnotobiotic rats · human intestinal microflora · Lactobacillus casei · yogurt


INTRODUCTION

The intestinal microflora is a complex ecosystem composed of a large variety of bacteria. The metabolic capacity of the flora is extremely diverse and can produce both positive and negative effects on the gut physiology (Gorbach 1986, Macfarlane and Cummings 1991). There is therefore great interest in the possibility of altering the intestinal microbiota in a beneficial way with the goal of improving the health of the host. Lactic acid bacteria have been considered potentially useful in this respect (Sanders 1993).

Lactic acid bacteria have been used traditionally in food fermentation for thousands of years. In fermented milks, these bacteria produce lactic acid as the primary end-product, along with acetic acid and ethanol, in the case of heterofermentative species. They also produce acetaldehyde, peptoglycan, peptides, vitamins and antimicrobial substances that contribute to the taste, texture, and potential health benefits of the products (Hartley and Denariaz 1993). Yogurt remains a staple food and is fermented using a combination of Lactobacillus bulgaricus and Streptococcus thermophilus. Other lactic acid bacteria are often combined with yogurt starters to produce fermented milks with specific desirable characteristics related to flavor or health properties (Robinson 1991).

Upon consumption, fermented milks deliver a large number of lactic acid bacteria into the gastrointestinal tract. These transiting microorganisms are capable of partially resisting gastric and bile acids and can therefore deliver enzymes and other substances into the intestines (Marteau and Rambaud 1993). Yogurt's ability to provide beta -galactosidase and to decrease lactose intolerance symptoms in lactose maldigesters has been frequently reported (Marteau and Rambaud 1993, Sanders 1993).

Lactic acid bacteria have also been reputed to modify the intestinal milieu. Some studies have shown that L. acidophilus, L. casei and Bifidobacterium bifidum can modify potentially harmful bacterial activities such as those of beta -glucuronidase and nitroreductase (Goldin and Gorbach 1984, Marteau et al. 1990). Few reports exist, however, that investigate the ability of lactic acid bacteria to alter the main fermentative processes of endogenous microflora. One recent study in humans showed that yogurt with or without B. longum did not modify fecal short-chain fatty acid (SCFA)3 concentrations (Bartram et al. 1994).

An in vitro model simulating the various compartments of the gastrointestinal tract recently demonstrated that the survival rate of lactic acid bacteria in the gut varied, depending on whether the bacteria were associated with other bacteria or were tested alone (Havenaar et al. 1994). Thus, the ability of the lactic acid bacteria in fermented milks to have an effect on the intestinal tract in vivo may depend on their combination in the product.

The objective of this study was to compare the influence of the consumption of milk fermented with L. casei and yogurt starters (LcYFM) to those of yogurt (Y), milk fermented with only L. casei (LcFM) and nonfermented milk (M) on the composition and metabolic activities of the intestinal microflora. Two experiments were performed successively. In the first study, germ-free (GF) rats were used to evaluate both the survival of ingested bacteria through the gastrointestinal tract and their metabolic profile in vivo. In the second study, rats born germ-free and inoculated with human intestinal microflora (HF rats) were used to determine the effects of the ingested fermented milks on the composition and metabolism of the intestinal microbiota.


MATERIALS AND METHODS

Animals. Sixty-four GF male Fischer rats, 2.5 mo old (265 ± 7 g) were used. The rats, which originated from UEPSD breeding unit (INRA, Jouy en Josas, France), were reared in sterile Texler-type isolators (La Cahlène, Vélizy, France) filled with a rapid transfer system, in an environmentally controlled room (25°C) with a 12-h light:dark cycle. Rats were given free access to their diets and to sterilized water, autoclaved for 20 min at 120°C. Thirty-two rats were maintained in the GF state, and 32 were inoculated with 1 mL of a 10-2 dilution of fresh human feces from a methane producer (HF rats). Fecal dilution was performed in an anaerobic cabinet (N2/H2/CO2, 85:10:5). All procedures were conducted in accordance with the institute's guide for the care and use of laboratory animals.

Experimental design. For 1 wk before the experiments, rats were given a human-like diet with the following composition (g/kg): mashed potatoes, 460; fish meal, 230; cellulose, 50; corn oil, 40; lard, 100; sucrose, 100; cholesterol, 0.15; and mineral and vitamin mixture, 20 (Andrieux and Sacquet 1986). The diet was sterilized by gamma irradiation at 45 kGy in plastic vacuum bags. When experiments started, GF or HF rats were assigned to four groups of eight and were transferred into sterile isolators, one isolator for each group. Rats were then given free access to diet offered as a paste containing 70% of powdered human-like diet that contain 30% M or one of three fermented milks, Y, LcFM or LcYFM. Milk and fermented milks were obtained from Danone (CIRDC, Le Plessis-Robinson, France). The products were conditioned in sterile pots and sealed with a double cover. The pots were provided on a daily basis to the isolators through a lock sterilized by peracetic acid (100 g/L). Milk and fermented milks contained the following (g/kg): protein, 3.7 and fat, 3.3. The fermented milks contained 5.2 g/kg and milk 12.7 g/kg of carbohydrates. The lactic acid bacteria composition of fermented milks is listed in Table 1.

Table 1. Concentration of lactic acid bacteria in fermented milks, diets and in feces of germ-free rats fed the fermented milks diets1,2

[View Table]

Collection of samples. In GF and HF rat studies, diets were given for a 4-wk period before fresh fecal samples (weight 0.1-0.2 g) were collected from each rat and immediately introduced into an anaerobic chamber to enumerate bacterial populations. Only HF rats were then transferred, for 4 d, into individual respiratory chambers, which could be connected and deconnected to the isolators to measure total hydrogen and methane production as previously described (LeCoz et al. 1989). After a 6-wk period, both GF and HF rats were killed by ether anesthesia, and their ceca were removed and weighed. Cecal pH was measured, and the contents were immediately frozen in liquid N2 and stored at -80oC until analyzed for enzymatic activities and bacterial metabolites.

Analyses. Lactic acid bacteria were analyzed in triplicate; three fecal samples from each GF rat were diluted from 10-6 to 10-9 in LCY medium4 and then plated (0.1 mL) on selective agars. For L. bulgaricus, MRS (Man Rogosa and Sharpe) medium was incubated anaerobically at 44oC for 72 h. MRS with bactoxgall was used for L. casei, and M17 medium was used for S. thermophilus; plates for both were incubated aerobically at 37oC for 72 h. After incubation, colonies were counted and observed microscopically. Fecal samples of HF rats were diluted to 10-9 in an anaerobic Freter's chamber in the prereduced liquid medium LCY. Dilutions of 10-7, 10-8 and 10-9 were plated (0.1 mL) on the following selective agars: BHI (brain heart infusion) neomycin medium for Bacteroides, Beerens medium for Bifidobacteria, GAPTS1 with azide for Enterococci, and DCA (desoxycholate acid) medium for enterobacteria. Plates containing BHI or Beerens medium were incubated at 37oC for 48 h in an anaerobic chamber, and those containing GAPTS1 and DCA were incubated aerobically at 37oC for 48 h. Cultures were prepared in triplicate. Colonies were counted and bacteria were observed microscopically.

Table 2. Cecal weight, pH, and bacterial metabolites in the cecal contents of germ-free rats fed milk or fermented milks1

[View Table]

After HF rats were maintained in a respiratory chamber for 4 d, gases were collected from the chamber atmosphere using a 20-mL capacity plastic syringe equipped with a three-way valve. Hydrogen and methane were immediatly measured using a Quintron apparatus (DP-Quintron Instruments, ABS, Saint Dié, France).

The glycolytic activities investigated were related to the metabolism of food (beta -galactosidase EC 3.2.1.23 and alpha -glucosidase EC 3.2.1.20) or were related to the release and enterohepatic recirculation of toxic substances (beta -glucosidase EC 3.2.1.21 and beta -glucuronidase EC 3.2.1.31). Enzyme assays were performed in an anaerobic chamber in 2-mL Eppendorf tubes. Glycolytic activity was measured by the rate of release of p-nitrophenols from p-nitrophenylglucoside. The reaction mixture contained 0.1 mL of a 5 mmol/L substrate solution and 0.2 mL of a 1:20 (v/v) dilution of the cecal sample in 0.1 mol/L phosphate buffer at pH 6.4. Incubation was at 37oC, and paranitrophenol concentration was measured according to the optical absorbency at 400 nm after the addition of 1.6 mL of 0.25 mol/L sodium carbonate. Enzyme activity was expressed as micromoles of product hydrolyzed per minute per gram of cecal sample.

SCFA, alcohol and lactic acid were measured in the cecal contents as markers of glycolytic fermentation, and ammonia and iso-acids as markers of proteolytic fermentation. SCFA and alcohol were analyzed after water extraction of acidified samples by using a gas-liquid chromatograph (Nelson 1020, Perkin-Elmer, St Quentin en Yvelines, France) equipped with a flame-ionization detector and a wide-bore column (15 m × 0.52 mm) (FSCAP Nukol, Supelco, L'Isle d'Abeau Chesnes, France) impregnated with SP 1000. Carrier gas (He) flow-rate was 10 mL/min, inlet temperature 175oC, column termperature 100oC, detector temperature 280oC, hydrogen and compressed air flow-rate 40 mL/min; 2ethylbutytrate was used as an internal standard.

L- and D-Lactate were determined enzymatically (Boehringer-Mannheim, Meylan, France), and ammonia was determined using the Berthelot method as adapted by Dropsy and Boy (1965).

Statistical analysis. Results are expressed as mean values and their standard errors. Data obtained from the study of GF rats and those obtained from the study of HF rats were analyzed separately by using one-way ANOVA (PCSM Software, Deltasoft, Meylan, France). If data were found to have heterogeneous variance, analysis was performed on data trasformed as square roots. If ANOVA indicated significant diet effects, means were compared using the Newman-Keuls test (PCSM Software). Statistical significance was accepted at P < 0.05.


RESULTS

Germ-free rat study. At the end of the experiment, body weight of GF rats ranged from 320 to 355 g (average 330 g) and intake ranged from 110 to 120 g per group without significant difference among treatment groups.

Lactic acid bacteria enumeration. The concentration of L. casei was more than 8 log10 colony-forming units (CFU)/g in LcFM and in LcYFM diets (Table 1). The concentration of L. bulgaricus in Y and LcYFM diets was 2 log lower than that of S. thermophilus. High levels of L. casei were found in feces of rats fed LcFM and LcYFM diets (Table 1). L. bulgaricus was detected in the feces of the Y diet group, but not in the LcYFM group. In contrast, S. thermophilus was not detected in the feces of rats fed Y, but was found in the feces of rats fed the LcYFM diet.

Bacterial metabolism. Compared with the results obtained in rats fed the M diet, rats fed fermented milk diets had a significantly lower cecal pH, with no difference in cecal weight (Table 2). In GF rats fed the M diet, only low concentrations of acetate and L-lactate were found. Acetate concentration was 1.8 times higher in rats fed LcFM and three times higher in those fed LcYFM than in those fed M or Y diets. Cecal lactate concentration was higher in rats fed fermented milk diets than in those fed the M diet. It was also significantly higher in rats fed the LcFM and LcYFM diets than in those fed the Y diet. D- and L-Lactate were produced in rats fed Y, but only the L isoform was found in rats given the LcFM and LcYFM diets. In the M group, only alpha -glucosidase and beta -galactosidase were detected. In the Y group, beta -galactosidase activity was significantly higher than in the M group, and beta -glucuronidase was detected (Table 3). In rats fed the LcFM diet, beta -galactosidase activity was as low as in the group fed the M diet, beta -glucuronidase activity was not different from rats fed the Y diet and beta -glucosidase was detected. In the LcYFM group, beta -galactosidase, alpha -glucosidase and beta -glucuronidase activities did not differ from those in rats fed the Y diet, whereas beta -glucosidase activity was not different from that in rats µ fed the LcFM diet.

Table 3. Bacterial glycolytic activities in the cecal content of germ-free rats fed milk or fermented milks1

[View Table]

Human flora-associated rat study. At the end of the experiment, the body weight of HF rats ranged from 315 to 348 g and intake ranged from 105 to 120 g per group without significant difference among treatments.

Bacterial examination of the microflora. HF rats fed the M diet had fecal flora characterized by a larger population of Bacteroides than Bifidobacterium, Enterococcus and enterobacteria (Table 4). Levels of these populations were not different in rats fed Y. Cecal concentration of Bifidobacterium was higher in the LcFM group than in others, and although there was no significant difference in Bifidobacterium in rats fed the LcYFM diet, 50% of rats in that group had Bifidobacterium cecal concentration higher than 8 log10 CFU/g.

Table 4. Composition of the fecal microflora in human flora-associated rats fed milk or fermented milks diets1

[View Table]

Bacterial metabolism. Daily hydrogen excretion did not differ among groups (Fig. 1), but methane excretion was 40% higher in rats fed the Y diet than in the other groups. Differences in cecal metabolism are shown in Table 5. The pH was significantly lower in rats fed the LcFM diet than in other groups. Only in the LcYFM group was the cecal SCFA concentration significantly higher than in the other groups. Acetate, propionate and butyrate were significantly higher in the LcYFM group than in others, but iso-acids (cumulated iso-butyrate and iso-valerate), L- and D-lactates, ethanol and ammonia concentrations were not different. When comparing the bacterial glycolytic activities (Fig. 2), beta -galactosidase, alpha -glucosidase and beta -glucosidase were significantly higher in the LcYFM group than in all other groups. beta -Glucuronidase activity was significantly lower in rats fed the Y and LcFM diets than in those fed M or LcYFM.
Fig. 1. Total daily production of hydrogen and methane in human flora-associated rats fed milk or fermented milks. Values are means ± SD, n = 8. Different letters indicate significantly different means (P < 0.05). Dietary group abbreviations: M, milk; Y, yogurt; LcFM, L. casei fermented milk; LcYFM, L. casei and yogurt starters fermented milk.
[View Larger Version of this Image (29K GIF file)]

Table 5. pH and cecal concentrations of short-chain fatty acids (SCFA), L- and D-lactate, ethanol and ammonia in human flora-associated rats fed milk or fermented milks diets1

[View Table]


Fig. 2. Bacterial glycolytic activities in cecal contents of human flora-associated rats fed milk or fermented milks. Values are means ± SD, n = 8. Different letters indicate significantly different means (P < 0.05). Dietary group abbreviations: M, milk; Y, yogurt; LcFM, L. casei fermented milk; LcYFM, L. casei and yogurt starters fermented milk.
[View Larger Version of this Image (22K GIF file)]


DISCUSSION

One of our objectives was to determine if L. casei and yogurt starters alone or in association with each other in fermented milks are able to survive transit through the upper gastrointestinal tract. At the time of this study, methods did not exist for distinguishing between the lactic acid bacteria in fermented milks and the autochthonous intestinal microflora; thus, human flora-associated rats were not appropriate for measuring bacterial survival. We therefore used germ-free rats for this portion of our experiment because they afford an opportunity to study bacterial survival rate and bacterial interactions under in vivo conditions.

The results obtained demonstrate that survival of bacteria differs among bacterial species and does in fact depend on the combination of lactic acid bacteria in the product. L. casei survives transit through the gastrointestinal tract when consumed in fermented milk diets, both as a monoculture and in association with yogurt starters, as shown by the large number of viable cells found in the feces. This result is consistent with the fact that L. casei is both acid and bile resistant and remains viable at a pH range of 3.0-7.0 (Goldin et al. 1992). With the use of an in vitro model, Havenaar et al. (1994) demonstrated that different strains of L. casei were able to survive transit through the gastrointestinal tract and reach the ileum in quantities sufficient to exert a physiologic effect.

Survival of bacteria from yogurt differed depending on whether or not these organisms were associated with L. casei. When rats ingested the Y diet, L. bulgaricus was recovered in the feces, whereas S. thermophilus was not detected. Conversely, L. bulgaricus was not detected, but S. thermophilus was recovered when rats were fed the LcYFM diet. Other studies on the survival of yogurt cultures using germ-free mice have led to inconsistent results. Bianchi Salvadori et al. (1984) found that L. bulgaricus was capable of implanting in the stomach and the large intestine. On the other hand, Besnier et al. (1984) reported that a single gavage in rats resulted in rapid fecal elimination of L. bulgaricus, whereas S. thermophilus remained at a high concentration in the feces. They further noted that the presence of both species persisted for 1 wk after discontinuation of the yogurt feeding. Interactions among bacterial species within the gut lumen may have led to reciprocal promotion of strains or to a partial or total inhibition of one or more species (Raibaud 1992).

The cecal contents of GF rats fed fermented milks correlates well with the metabolic profile of the lactic acid bacteria that survived in the colon: D-lactate was produced by L. bulgaricus in rats fed Y, and L-lactate was the major end product of L. casei and S. thermophilus in rats fed the LcFM or LcYFM diets. The slight production of acetate can most likely be attributed to L. casei, which was the only facultatively heterofermentative species used in the study (Hartley and Denariaz 1993).

Fermented milks likely improve the balance of the intestinal microflora either by supplying beneficial bacteria or by increasing the number and activity of endogenous bacteria that possess health-promoting properties. Such a hypothesis implies that ingested bacteria reach the colon in a live state. In humans, as we observed for GF rats, L. casei can be recovered in the feces during and for up to 2 wk after discontinuation of ingestion of the bacteria (Goldin et al. 1992, Ling et al. 1992, Saxelin et al. 1991). The ability of other lactic acid bacteria to survive is less clear. Bianchi Salvadori et al. (1978) found live L. bulgaricus and S. thermophilus in the feces of humans after yogurt consumption, whereas Pedrosa et al. (1995) did not. Hargrove and Alford (1978) found that in conventional rats, L. bulgaricus was not always present and S. thermophilus never survived beyond the upper small intestine.

When human microflora are inoculated in rats, they maintain their major metabolic characteristics (Andrieux et al. 1991). The specific changes observed in this study in the endogenous bacterial population and in bacterial metabolism of HF rats suggest that the lactic acid bacteria modified the intestinal medium in specific ways. We found that LcFM significantly increased the amount of endogenous Bifidobacterium in the feces. Similar effects have been described in humans (Hayatsu and Hayatsu 1993, Saxelin et al. 1991, Sepp et al. 1993). This may be beneficial because Bifidobacteria have been associated with many health and nutritional benefits (Ballongue 1993). The low cecal pH observed in the LcFM group may have been due to the production of formic acid by Bifidobacteria, and not due to the survival of L. casei because lactate and acetate, the main products of L. casei, were not enhanced in cecal contents.

In addition to an increase in Bifidobacterium, LcFM significantly reduced beta -glucuronidase activity, which has been implicated in colon carcinogenesis (Goldin and Gorbach 1984). Other reports have noted a decrease in beta -glucuronidase activity in rats (Goldin and Gorbach 1984) and in humans (Ling et al. 1994) during ingestion of L. casei.

A decrease in beta -glucuronidase activity may be related to a change in intestinal pH and/or to a modification in the composition of the intestinal flora. In our experiment, beta -glucuronidase activity was lower in both LcFM and Y groups than in the M group; however, although the LcFM diet led to a decrease in pH and a change in Bifidobacterium population, the Y diet showed no influence on cecal pH or the composition of the endogenous intestinal microflora. L. bulgaricus was found in the feces of GF rats fed Y, and L. casei in those fed LcFM diet, and both bacteria had similar low levels of beta -glucuronidase but different levels of beta -galactosidase and fermentative metabolites, as shown in Table 3. These results suggest that lactic acid bacteria can potentially modify deleterious bacterial activity such as that of beta -glucuronidase by more than one mechanism, depending on the species and strains present in the fermented milk. These mechanisms remain to be found.

We report here that the association of L. casei and yogurt starters in fermented milk (LcYFM) leads to a specific effect that clearly differs from the sum of the effects found in Y and LcFM. For LcYFM, neither pH nor beta -glucuronidase activity was modified, and the amount of Bifidobacterium tended to be higher in only 50% of rats in this group. The particular effect of this new product was an increase in the activities of beta -galactosidase and alpha - and beta -glucosidase. In addition, there was a concomitant increase in total and specific SCFA concentrations.

These changes, specific to the LcYFM diet, may be attributable to the larger number of bacteria that reach the colon (twice that of Y and LcFM diets), as shown by the results in GF rats (Table 1). L. casei and S. thermophilus are both beta -galactosidase producers and are able to hydrolyze carbohydrates other than lactose; they might provide glycolytic enzymes in the intestinal tract. Glycolytic activities, however, were low in GF rats compared with HF rats. Morevoer, the increase in acetate, propionate and butyrate in the ceca of HF rats fed the LcYFM diet without a concomitant change in lactate concentration is not characteristic of lactic acid bacterial metabolism. Thus, endogenous bacteria clearly are implicated in the glycolytic enzyme induction and fermentative process.

Whatever the mechanism for the above changes, the increase in acetate, propionate and butyrate may be beneficial for the host. These SCFA are major end-products of microbial fermentation. They are absorbed from the colon and are an important source of energy for tissues, and especially of butyrate, which is the preferred energy source for colonocytes (Macfarlane and Cummings 1991). In addition, the enhanced beta -galactosidase and alpha -glucosidase activities found with the LcYFM diet offer a number of advantages for the host. The importance of beta -galactosidase in improving lactose digestion is well recognized, and alpha -glucosidase may improve fermentation of resistant starch, which leads to butyrate production, improved bowel habits and increased stool output (Macfarlane and Cummings 1991). On the other hand, the increase in beta -glucosidase activity is less clear because this activity has been implicated in both the generation of toxins (Mallett and Rowland, 1988) and of bacterial derivatives, which might be protective against chemically induced cancer (Roland et al. 1993).

In conclusion, our results point out differences in the survival of lactic acid bacteria in in vivo conditions, depending on the combination of bacteria in the fermented milk. They show that ingestion of lactic acid bacteria influences the composition and/or metabolism of endogenous microbiota. The new association of L. casei with yogurt cultures has specific effects of its own that differ from the simple addition of the effects of L. casei-fermented milk and yogurt. These effects may offer potential benefits for health.


ACKNOWLEDGMENTS

The authors thank Martine Bensaada, Françoise Popot and Pierre Vaissade for excellent technical assistance.


FOOTNOTES

1   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
2   To whom correspondence should be addressed.
3   Abbreviations used: CFU, colony forming units; GF rats, germ-free rats; HF rats, human flora-associated rats; LcFM Lactobacillus casei fermented milk; LcYFM, milk fermented by Lactobacillus casei and yogurt starters (Lactobacillus bulgaricus and Streptococcus thermophilus); M, milk; SCFA, short-chain fatty acids; Y, yogurt.
4   Culture media. The various media had the following compositions (g/L): LCY medium: casein enzymic hydrolysate (U.S. Biochemical, Cleveland, OH), 2; yeast extract (Difco, Detroit, MI), 2; NaCl, 5 and KH2PO4, 1. Man Rogosa and Sharpe medium (MRS) (Difco): at medium pH adjusted to 5.4, 55; MRS medium with bacto-oxgall, 1 (Difco). M17 medium: at pH 7.2, polytone (BioMérieux, Paris, France), 5; Soyase (BioMérieux), 5; yeast extract (BioMérieux), 2.5; meat extract (BioMérieux), 5; glucose, 5; ascorbic acid, 0.5; phosphate glycerol, 19; magnesium sulfate, 7; H20, 0.25. BHI medium: brain heart infusion (Difco), 37; yeast extract (Difco), 5; haemin, 0.005; BHI plus neomycin sulphate, 0.2. Beerens medium (Beerens 1990). GAPTS1 medium: yeast extract (Difco), 10; peptone, 15.0; tryptone, 10.0; sucrose, 1.0; sodium azide, 3.0 (pH 7.5). DCA agar medium: peptone, 10.0; lactose (Sigma, L'Isle d'Abeau Chesnes, France), 10.0; sodium deoxycholate (Sigma), 5.0; NaCl, 5.0; Na2HPO4, 2.0; iron citrate, 1.0; sodium citrate, 1.0; neutral red, 0.03.

Manuscript received 3 March 1997. Initial reviews completed 15 April 1997. Revision accepted 26 June 1997.


LITERATURE CITED


0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
R. Oozeer, N. Goupil-Feuillerat, C. A. Alpert, M. van de Guchte, J. Anba, J. Mengaud, and G. Corthier
Lactobacillus casei Is Able To Survive and Initiate Protein Synthesis during Its Transit in the Digestive Tract of Human Flora-Associated Mice
Appl. Envir. Microbiol., July 1, 2002; 68(7): 3570 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. K. Buddington and E. Weiher
The Application of Ecological Principles and Fermentable Fibers to Manage the Gastrointestinal Tract Ecosystem
J. Nutr., July 1, 1999; 129(7): 1446 - 1446.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djouzi, Z.
Right arrow Articles by Szylit, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djouzi, Z.
Right arrow Articles by Szylit, O.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]